AU2002211005A1 - Lipid peroxide-lowering compositions - Google Patents

Lipid peroxide-lowering compositions

Info

Publication number
AU2002211005A1
AU2002211005A1 AU2002211005A AU1100502A AU2002211005A1 AU 2002211005 A1 AU2002211005 A1 AU 2002211005A1 AU 2002211005 A AU2002211005 A AU 2002211005A AU 1100502 A AU1100502 A AU 1100502A AU 2002211005 A1 AU2002211005 A1 AU 2002211005A1
Authority
AU
Australia
Prior art keywords
lipid peroxide
lowering compositions
lowering
compositions
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211005A
Inventor
Tatsuhito Kondo
Masato Nakayama
Tsuneoki Ohsawa
Ippei Shimizu
Ikuo Takagi
Yasuhiro Torizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2002211005A1 publication Critical patent/AU2002211005A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002211005A 2000-11-07 2001-11-05 Lipid peroxide-lowering compositions Abandoned AU2002211005A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000339457 2000-11-07
JP2000383053 2000-12-18
JP2000-339457 2000-12-18
JP2000-383053 2000-12-18
PCT/JP2001/009662 WO2002038151A1 (en) 2000-11-07 2001-11-05 Lipid peroxide-lowering compositions

Publications (1)

Publication Number Publication Date
AU2002211005A1 true AU2002211005A1 (en) 2002-05-21

Family

ID=26603539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211005A Abandoned AU2002211005A1 (en) 2000-11-07 2001-11-05 Lipid peroxide-lowering compositions

Country Status (7)

Country Link
US (1) US6998422B2 (en)
CN (1) CN1240379C (en)
AU (1) AU2002211005A1 (en)
CA (1) CA2428204A1 (en)
HK (1) HK1061978A1 (en)
TW (1) TWI285105B (en)
WO (1) WO2002038151A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284529B (en) * 2000-12-18 2007-08-01 Sankyo Co A composition for lowering triglyceride
MXPA05000050A (en) * 2002-07-03 2005-04-08 Esperion Therapeutics Inc Compositions comprising panthetine for the treatment of dyslipidemia.
US20050192347A1 (en) * 2003-12-23 2005-09-01 Dasseux Jean-Louis H. Urea and thiourea compounds and compositions for cholesterol management and related uses
JP5080011B2 (en) * 2005-02-28 2012-11-21 第一三共ヘルスケア株式会社 Composition for increasing glutathione peroxidase activity
MX2009009126A (en) * 2007-03-01 2009-10-28 Concourse Health Sciences Llc Isomers of inositol niacinate and uses thereof.
US10874625B2 (en) * 2009-11-02 2020-12-29 Plant Sensory Systems, Llc Methods for the biosynthesis of taurine or hypotaurine in cells
BR112012010394A2 (en) * 2009-11-02 2017-06-27 Plant Sensory Systems Llc method for biosynthesis of taurine or hypotaurin in cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019891B2 (en) 1978-12-01 1985-05-18 第一製薬株式会社 Drug-induced fatty liver agent
DK149080C (en) 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS5869813A (en) 1981-10-23 1983-04-26 Sogo Yatsukou Kk Serum lipid depressant
JPS6041611A (en) 1983-08-17 1985-03-05 Sankyo Co Ltd Blood lipid improving agent
US5662934A (en) * 1993-01-05 1997-09-02 Najarian; Thomas Compositions and methods for lowering cholesterol while maintaining antioxidant levels
AU732465B2 (en) 1996-04-17 2001-04-26 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
DE69837610T2 (en) * 1997-07-31 2008-01-03 Kos Life Sciences, Inc., Weston COAT COMPARTMENT CONTAINING NICOTIC ACID OR A SUBSTANCE FOR METABOLISING TO NICOTIC ACID IN DELAYED FORM AND AN HMG-COA REDUCTASE IN THE COAT FOR IMMEDIATE RELEASE
US6245797B1 (en) * 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6436406B1 (en) * 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
US6916849B2 (en) * 2000-10-23 2005-07-12 Sankyo Company, Limited Compositions for improving lipid content in the blood

Also Published As

Publication number Publication date
WO2002038151A1 (en) 2002-05-16
US20030229124A1 (en) 2003-12-11
CN1486181A (en) 2004-03-31
CA2428204A1 (en) 2002-05-16
HK1061978A1 (en) 2004-10-15
US6998422B2 (en) 2006-02-14
TWI285105B (en) 2007-08-11
CN1240379C (en) 2006-02-08

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001282877A1 (en) Cosmetic compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2473401A (en) Organosiloxane compositions
AU2001265919A1 (en) Cosmetic compositions
AUPQ875700A0 (en) Combination compositions
AU2002214324A1 (en) Medicinal compositions
AU2002237229A1 (en) Detergent compositions
AU2001241098A1 (en) Composition
AU2001273919A1 (en) Pharmaceutical compositions
AU2001270235A1 (en) Oral compositions
AU2001272422A1 (en) Detergent compositions
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001275201A1 (en) Acne-treating composition
AU2001214419A1 (en) Fragrance compositions
AU2001294245A1 (en) Compositions for improving lipid metabolism
AU2001245610A1 (en) Detergent compositions
AU2001240520A1 (en) Detergent compositions
AU2001287852A1 (en) Composition
AU2001230196A1 (en) Detergent compositions
AU2001235764A1 (en) Compositions
AU2001290669A1 (en) Oral compositions
AU2001256202A1 (en) Cosmetic compositions
AU2000274826A1 (en) Cosmetic compositions